NutraSift: The nutraceutical innovation podcast

Amaranth: The only grain with meaningful nitrate content for sports performance

5 min · 22 de may de 2026
Portada del episodio Amaranth: The only grain with meaningful nitrate content for sports performance

Descripción

Amaranth leaves contain high levels of inorganic nitrate, the same compound found in beetroot that converts to nitric oxide for vasodilation and athletic performance. But unlike beetroot (a root vegetable), amaranth is a complete protein source AND a nitrate source. Arjuna Natural's Oxystorm positions amaranth leaf extract as a nitric oxide ingredient, an entirely different market than "ancient grain." Publications of interest: https://pmc.ncbi.nlm.nih.gov/articles/PMC7359009/ https://pubmed.ncbi.nlm.nih.gov/27131407/ https://pmc.ncbi.nlm.nih.gov/articles/PMC5969023/

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de NutraSift: The nutraceutical innovation podcast!

Empezar

2 meses por 1 €

Después 4,99 € / mes · Cancela cuando quieras.

  • Podcasts exclusivos
  • 20 horas de audiolibros / mes
  • Podcast gratuitos

Todos los episodios

78 episodios

Portada del episodio Can social media serve as Real-Word Data for supplements?

Can social media serve as Real-Word Data for supplements?

What if the millions of supplement experiences shared online could point us toward what actually works? We dig into a first-of-its-kind study that matched 216,350 Reddit comments against 15,760 clinical-trial records to test whether social media chatter lines up with real evidence. The findings are striking: the most-discussed ingredients were more than 3× as likely to have trial evidence behind them (39% vs. 11%), and the effect scaled steadily. The more a benefit was discussed, the stronger its link to clinical support (odds ratios climbing from 2.1 to 5.5). We unpack why this matters. Supplements largely escape the post-market surveillance that tracks prescription drugs, leaving over-the-counter use nearly invisible, even as lived experiences pile up in public forums. We explore how consensus (not just volume) carries independent signal, how contested claims might hint at personalised supplementation, and why aggregated social data, treated carefully as a measurement instrument, could become a credible real-world resource for prioritising hypotheses and designing sharper studies. Not a replacement for clinical trials, but a powerful new lens. You can find the full publication: https://www.medrxiv.org/content/10.64898/2026.06.26.26356690v1 [https://www.medrxiv.org/content/10.64898/2026.06.26.26356690v1]

Ayer9 min